Effect of RU‐486 and Related Compounds on the Proliferation of Cultured Macrophages

American Journal of Reproductive Immunology

Volumn 34, Issue 4, 1995, Pages 248-256

  ROBERTS, C P ^a   PARTHASARATHY, S ^a   GULATI, R ^a   HOROWITZ, I ^a   MURPHY, A A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antioxidant; antiprogestin; Endometriosis; glucocorticoid; RAW macrophages

Indexed keywords

ANTIGESTAGEN; DITHIOCARBAMIC ACID; GLUCOCORTICOID ANTAGONIST; MIFEPRISTONE; PROGESTERONE; PYRROLIDINE DERIVATIVE;

CONFERENCE PAPER; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; ENDOMETRIOSIS; HUMAN; HUMAN CELL; LYMPHOID CELL; MACROPHAGE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTIOXIDANTS; CELL DIVISION; GLUCOCORTICOIDS; GROWTH INHIBITORS; HORMONE ANTAGONISTS; HUMAN; MACROPHAGES; MIFEPRISTONE; PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0028882704     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1995.tb00949.x     Document Type: Article

References (38)

1. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis
2. Endometriosis, macrophages and adhesions
3. The role of the peritoneal macrophage on the infertility associated with endometriosis
4. Immune system and endometriosis
5. Expression of interleukin‐1 (IL‐1) beta messenger ribonucleic acid (mRNA) and IL‐1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis
6. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro
7. The role of macrophage colony stimulating factor in the peritoneal fluid in infertile patients with endometriosis
8. Some antioxidants inhibit, in a coordinate fashion, the production of tumor necrosis factor‐alpha, IL‐beta, and IL‐6 by human peripheral blood mononuclear cells
9. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
10. Induction of endothelial cell expression of granulocyte and macrophage colony‐stimulating factors by modified low‐density lipoproteins
11. Dexamethasone upregulates granulocyte‐macrophage colony stimulating factor receptor expression on human monocytes
12. Dexamethasone upregulates granulocyte‐macrophage colony‐stimulating factor receptor expression on human monocytes
13. Dexamethasone modulates lipoprotein metabolism in cultured human monocyte‐derived macrophages. Stimulation of scavenger receptor activity
14. Endocrine responses to long‐term administration of the antiprogesterone RU‐486 in patients with pelvic endometriosis
15. Regression of uterine leiomyomata in response to the antiprogesterone RU‐486
16. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU‐486
17. RU‐486, a progestin and glucocorticoid antagonist, inhibits growth of breast cancer cells via the progesterone receptor
18. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
19. Growth stimulation of human T47D human breast cancer cells by the antiprogestin RU‐486
20. Endometrial and pituitary responses to the steroid antiprogestin RU‐486 in postmenopausal women
21. Antioxidant: A new role for RU‐486 and related compounds
22. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation
23. Modification of mitogen‐induced proliferation of murine splenic lymphocytes by in vitro tocopherol
24. Effects of the synthetic anti‐oxidant, probucol, on the U937 monoblastoid cell line
25. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat‐fed rabbits
26. Specificity and inhibition of glucocorticoid‐induced macrocortin secretion from rat peritoneal macrophages
27. Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences
28. Minimally modified low density lipoprotein‐induced inflammatory responsive endothelial cells are mediated by cyclic adenosine monophosphate
29. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy
30. Termination of early pregnancy by the progesterone antagonist RU‐486 (Mefipristone)
31. RU‐486—A decade on today and tomorrow
32. Dose‐response relationships of RU‐486
33. Metabolism and serum binding of RU 486 in women after various doses
34. Distribution of RU 486 and its demethylated metabolites in humans
35. Pharmakokinetics and metabolism of RU 486
36. Probucol treatment affects the cellular composition but not anti‐oxi‐dized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits
37. Antiproliferative properties of aminosteroid antioxidants on cultured cancer cells
38. Inhibition of proliferation of fibroblasts by lazaroids (21‐aminosteroids)